Drugmakers push forward on large-scale production of coronavirus vaccines

Coronavirus vaccine developers working with the U.S. government are churning out doses of their experimental shots en masse, shifting to commercial production before clinical testing is complete in an effort to meet ambitious timelines for widespread distribution and vaccination.